Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial

Sarah Baker, Linden Lechner, Mitchell Liu, Jee Suk Chang, Ella Mae Cruz-Lim, Ben Mou, Will Jiang, Alanah Bergman, Devin Schellenberg, Abraham Alexander, Tanya Berrang, Andrew Bang, Nick Chng, Quinn Matthews, Hannah Carolan, Fred Hsu, Stacey Miller, Siavash Atrchian, Elisa Chan, Clement Ho, Islam Mohamed, Angela Lin, Vicky Huang, Ante Mestrovic, Derek Hyde, C. Lund, Howard Pai, Boris Valev, Shilo Lefresne, Gregory Arbour, Irene Yu, Scott Tyldesley, Rob A. Olson